Print Page     Close Window     

SEC Filings

10-Q
BIOTIME INC filed this Form 10-Q on 08/09/2017
Entire Document
 

IN WITNESS WHEREOF, the parties hereto have duly executed this Agreement effective as of the date first set forth above.

   
Cell Cure Neurosciences Ltd.
 

Name:
Dr. Charles Irving
Title:
CEO

 
 
HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD.
Name:
   
Title:
   

I hereby confirm that I have read and understood this Agreement and that I will abide by its terms.

   
Professor [ * ]
 
 
[ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
 
- 55 -

© Copyright BioTime, Inc.